NODAL PERIPHERAL T-CELL LYMPHOMA WITH TFH PHENOTYPE
Clinical trials for NODAL PERIPHERAL T-CELL LYMPHOMA WITH TFH PHENOTYPE explained in plain language.
Never miss a new study
Get alerted when new NODAL PERIPHERAL T-CELL LYMPHOMA WITH TFH PHENOTYPE trials appear
Sign up with your email to follow new studies for NODAL PERIPHERAL T-CELL LYMPHOMA WITH TFH PHENOTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough lymphoma: targeted drug soquelitinib faces standard care in phase 3 trial
Disease control Recruiting nowThis study tests a new drug called soquelitinib against standard single-agent treatments in 150 adults with certain types of T-cell lymphoma that have come back or not responded to prior therapy. The goal is to see if soquelitinib can delay cancer progression better than current …
Matched conditions: NODAL PERIPHERAL T-CELL LYMPHOMA WITH TFH PHENOTYPE
Phase: PHASE3 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 03:53 UTC
-
Massive T-Cell lymphoma database aims to unlock better treatments
Knowledge-focused Recruiting nowThis study is creating a large database of information from 1,000 people with T-cell lymphoma. Researchers will collect medical records and tumor samples to learn more about the disease and how to improve care. No new treatments are being tested; the goal is to gather data for fu…
Matched conditions: NODAL PERIPHERAL T-CELL LYMPHOMA WITH TFH PHENOTYPE
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC